The peptide activated the Nrf2 system, reduced intracellular oxidative stress and resulted in increased tyrosine hydroxylase-positive dopaminergic cells in the substantia nigra and increased dopamine content in the barins of 6-hydroxydopamine and MPTP animal models of PD. Here, NFE2L2 is linked to Parkinson disease.